{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:26:09Z","timestamp":1787027169537,"version":"build-2736575974"},"reference-count":109,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>Cancer incidence and mortality are growing worldwide. With a lack of optimal treatments across many cancer types, there is an unmet need for the development of novel treatment strategies for cancer. One approach is to leverage the immune system for its ability to survey for cancer cells. However, cancer cells evolve to evade immune surveillance by establishing a tumor microenvironment (TME) that is marked by remarkable immune suppression. Macrophages are a predominant immune cell within the TME and have a major role in regulating tumor growth. In the TME, macrophages undergo metabolic reprogramming and differentiate into tumor-associated macrophages (TAM), which typically assume an immunosuppressive phenotype supportive of tumor growth. However, the plasticity of macrophage biology offers the possibility that macrophages may be promising therapeutic targets. Among the many determinants in the TME that may shape TAM biology, platelets can also contribute to cancer growth and to maintaining immune suppression. Platelets communicate with immune cells including macrophages through the secretion of immune mediators and cell-cell interaction. In other diseases, altering platelet secretion and cell-cell communication has been shown to reprogram macrophages and ameliorate inflammation. Thus, intervening on platelet-macrophage biology may be a novel therapeutic strategy for cancer. This review discusses our current understanding of the interaction between platelets and macrophages in the TME and details possible strategies for reprogramming macrophages into an anti-tumor phenotype for suppressing tumor growth.<\/jats:p>","DOI":"10.3389\/fphys.2023.1250982","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T14:45:07Z","timestamp":1692888307000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["A role for platelets in metabolic reprogramming of tumor-associated macrophages"],"prefix":"10.3389","volume":"14","author":[{"given":"Ying","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel Boadi","family":"Amoafo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philomena","family":"Entsie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory L.","family":"Beatty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Liverani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e004695","DOI":"10.1136\/jitc-2022-004695","article-title":"Therapeutic targeting of PD-1\/PD-L1 blockade by novel small-molecule inhibitors recruits cytotoxic T cells into solid tumor microenvironment","volume":"10","author":"Acurcio","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/intimm\/8.5.765","article-title":"Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes","volume":"8","author":"Agata","year":"1996","journal-title":"Int. Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"15477","DOI":"10.1038\/s41598-021-94735-y","article-title":"Interactions of platelets with circulating tumor cells contribute to cancer metastasis","volume":"11","author":"Anvari","year":"2021","journal-title":"Sci. Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1158\/2326-6066.CIR-20-0317","article-title":"Arginase therapy combines effectively with immune checkpoint blockade or agonist anti-OX40 immunotherapy to control tumor growth","volume":"9","author":"Badeaux","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12964-020-0530-4","article-title":"Tumor microenvironment complexity and therapeutic implications at a glance","volume":"18","author":"Baghban","year":"2020","journal-title":"Cell. Commun. Signal"},{"key":"B6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/14737140.2017.1270208","article-title":"Cancer immunotherapy: activating innate and adaptive immunity through CD40 agonists","volume":"17","author":"Beatty","year":"2017","journal-title":"Expert Rev. Anticancer Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.cmet.2019.07.015","article-title":"Podoplanin-expressing macrophages promote lymphangiogenesis and lymphoinvasion in breast cancer","volume":"30","author":"Bieniasz-Krzywiec","year":"2019","journal-title":"Cell. Metab."},{"key":"B8","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1158\/0008-5472.CAN-15-2263","article-title":"Tissue factor induced by epithelial-mesenchymal transition triggers a procoagulant state that drives metastasis of circulating tumor cells","volume":"76","author":"Bourcy","year":"2016","journal-title":"Cancer Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"693974","DOI":"10.3389\/fimmu.2021.693974","article-title":"CLEC-2 prevents accumulation and retention of inflammatory macrophages during murine peritonitis","volume":"12","author":"Bourne","year":"2021","journal-title":"Front. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"665534","DOI":"10.3389\/fonc.2021.665534","article-title":"Platelet-cancer interplay: molecular mechanisms and new therapeutic avenues","volume":"11","author":"Braun","year":"2021","journal-title":"Front. Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"16041","DOI":"10.1038\/ncomms16041","article-title":"Natural variation of macrophage activation as disease-relevant phenotype predictive of inflammation and cancer survival","volume":"8","author":"Buscher","year":"2017","journal-title":"Nat. Commun."},{"key":"B12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1182\/blood-2004-02-0434","article-title":"Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis","volume":"104","author":"Camerer","year":"2004","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1007\/s10875-012-9847-0","article-title":"Cancer-related inflammation","volume":"33","author":"Candido","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.celrep.2019.06.062","article-title":"Platelets promote macrophage polarization toward pro-inflammatory phenotype and increase survival of septic mice","volume":"28","author":"Carestia","year":"2019","journal-title":"Cell. Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1016\/j.ymthe.2022.06.019","article-title":"P2Y12 inhibitor clopidogrel inhibits renal fibrosis by blocking macrophage-to-myofibroblast transition","volume":"30","author":"Chen","year":"2022","journal-title":"Mol. Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40364-020-00207-2","article-title":"Role of platelet biomarkers in inflammatory response","volume":"8","author":"Chen","year":"2020","journal-title":"Biomark. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"825892","DOI":"10.3389\/fimmu.2022.825892","article-title":"Platelets as key factors in inflammation: focus on cd40l\/CD40","volume":"13","author":"Cognasse","year":"2022","journal-title":"Front. Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.trecan.2016.11.008","article-title":"Targeting TGF-beta signaling in cancer","volume":"3","author":"Colak","year":"2017","journal-title":"Trends Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e12710","DOI":"10.1002\/rth2.12710","article-title":"Clustering extent-dependent differential signaling by CLEC-2 receptors in platelets","volume":"6","author":"Dangelmaier","year":"2022","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"B20","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1186\/s12879-018-3478-x","article-title":"Immunohistochemical characterization of the M4 macrophage population in leprosy skin lesions","volume":"18","author":"De Sousa","year":"2018","journal-title":"BMC Infect. Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"jcs214551","DOI":"10.1242\/jcs.214551","article-title":"C-type lectin-like receptor 2 (CLEC-2)-dependent dendritic cell migration is controlled by tetraspanin CD37","volume":"131","author":"De Winde","year":"2018","journal-title":"J. Cell. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1007\/s00262-020-02758-7","article-title":"Inflammatory cell-associated tumors. Not only macrophages (TAMs), fibroblasts (TAFs) and neutrophils (TANs) can infiltrate the tumor microenvironment. The unique role of tumor associated platelets (TAPs)","volume":"70","author":"Dymicka-Piekarska","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3390\/cancers12010250","article-title":"Antiplatelet drug ticagrelor enhances chemotherapeutic efficacy by targeting the novel P2Y12-AKT pathway in pancreatic cancer cells","volume":"12","author":"Elaskalani","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"6709","DOI":"10.3390\/ijms24076709","article-title":"The signaling pathway of the ADP receptor P2Y(12) in the immune system: recent discoveries and new challenges","volume":"24","author":"Entsie","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.21037\/atm.2019.08.06","article-title":"Platelet-derived microparticles promote phagocytosis of oxidized low-density lipoprotein by macrophages, potentially enhancing foam cell formation","volume":"7","author":"Feng","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ccr.2013.01.008","article-title":"Role of macrophage targeting in the antitumor activity of trabectedin","volume":"23","author":"Germano","year":"2013","journal-title":"Cancer Cell."},{"key":"B27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1146\/annurev.immunol.16.1.111","article-title":"CD40 and CD154 in cell-mediated immunity","volume":"16","author":"Grewal","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3389\/fimmu.2020.00938","article-title":"Myeloid cell-derived arginase in cancer immune response","volume":"11","author":"Grzywa","year":"2020","journal-title":"Front. Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.ccell.2018.03.002","article-title":"The platelet lifeline to cancer: challenges and opportunities","volume":"33","author":"Haemmerle","year":"2018","journal-title":"Cancer Cell."},{"key":"B30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1182\/blood.v94.11.3791","article-title":"Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules","volume":"94","author":"Heijnen","year":"1999","journal-title":"Blood"},{"key":"B32","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41423-021-00833-2","article-title":"Microenvironmental influences on T cell immunity in cancer and inflammation","volume":"19","author":"Heintzman","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1172\/JCI84427","article-title":"The impact of hypoxia on tumor-associated macrophages","volume":"126","author":"Henze","year":"2016","journal-title":"J. Clin. Invest."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.4049\/jimmunol.1100889","article-title":"M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells","volume":"187","author":"Heusinkveld","year":"2011","journal-title":"J. Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"112131","DOI":"10.1016\/j.celrep.2023.112131","article-title":"Platelet-instructed SPP1(+) macrophages drive myofibroblast activation in fibrosis in a CXCL4-dependent manner","volume":"42","author":"Hoeft","year":"2023","journal-title":"Cell. Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"113927","DOI":"10.1016\/j.biopha.2022.113927","article-title":"The role and pharmacological properties of P2Y12 receptor in cancer and cancer pain","volume":"157","author":"Hu","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"B37","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3390\/cancers11020240","article-title":"The role of platelets in the tumor-microenvironment and the drug resistance of cancer cells","volume":"11","author":"Huong","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B38","doi-asserted-by":"publisher","first-page":"807600","DOI":"10.3389\/fimmu.2021.807600","article-title":"Platelet CLEC2-podoplanin Axis as a promising target for oral cancer treatment","volume":"12","author":"Hwang","year":"2021","journal-title":"Front. Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"44776","DOI":"10.1074\/jbc.M111.289793","article-title":"Real-time imaging reveals that P2Y2 and P2Y12 receptor agonists are not chemoattractants and macrophage chemotaxis to complement C5a is phosphatidylinositol 3-kinase (PI3K)- and p38 mitogen-activated protein kinase (MAPK)-independent","volume":"286","author":"Isfort","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1038\/emm.2013.85","article-title":"Cancer cell metabolism: implications for therapeutic targets","volume":"45","author":"Jang","year":"2013","journal-title":"Exp. Mol. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/bjc.2017.214","article-title":"Platelet releasate promotes breast cancer growth and angiogenesis via VEGF-integrin cooperative signalling","volume":"117","author":"Jiang","year":"2017","journal-title":"Br. J. Cancer"},{"key":"B42","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s13046-021-02041-2","article-title":"Statins: A repurposed drug to fight cancer","volume":"40","author":"Jiang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"265","DOI":"10.7150\/thno.27246","article-title":"Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin \u03b23\/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery","volume":"9","author":"Jin","year":"2019","journal-title":"Theranostics"},{"key":"B44","doi-asserted-by":"publisher","first-page":"110430","DOI":"10.1016\/j.cellsig.2022.110430","article-title":"Tumor-associated macrophages improve hypoxia-induced endoplasmic reticulum stress response in colorectal cancer cells by regulating TGF-\u03b21\/SOX4","volume":"99","author":"Kang","year":"2022","journal-title":"Cell. Signal"},{"key":"B45","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3978\/j.issn.2218-6751.2015.10.09","article-title":"Platelets and their role in cancer evolution and immune system","volume":"4","author":"Karachaliou","year":"2015","journal-title":"Transl. Lung Cancer Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13045-021-01053-x","article-title":"Novel therapies emerging in oncology to target the TGF-beta pathway","volume":"14","author":"Kim","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3109\/09537104.2010.497231","article-title":"P2Y12 receptor in platelet activation","volume":"22","author":"Kim","year":"2011","journal-title":"Platelets"},{"key":"B48","doi-asserted-by":"publisher","first-page":"4476","DOI":"10.1073\/pnas.1525360113","article-title":"Ang-2\/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival","volume":"113","author":"Kloepper","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B49","doi-asserted-by":"publisher","first-page":"101198","DOI":"10.1016\/j.redox.2019.101198","article-title":"Metabolic programming of macrophage functions and pathogens control","volume":"24","author":"Koo","year":"2019","journal-title":"Redox Biol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"8412","DOI":"10.3390\/ijms21218412","article-title":"CC chemokines in a tumor: A review of pro-cancer and anti-cancer properties of the ligands of receptors CCR1, CCR2, CCR3, and CCR4","volume":"21","author":"Korbecki","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1111\/cas.13580","article-title":"Podoplanin: an emerging cancer biomarker and therapeutic target","volume":"109","author":"Krishnan","year":"2018","journal-title":"Cancer Sci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/1479-5876-10-183","article-title":"TGF-beta - an excellent servant but a bad master","volume":"10","author":"Kubiczkova","year":"2012","journal-title":"J. Transl. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1084\/jem.146.3.665","article-title":"Suppression of in vitro cytotoxic response by macrophages due to induced arginase","volume":"146","author":"Kung","year":"1977","journal-title":"J. Exp. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"E3053","DOI":"10.1073\/pnas.1411082111","article-title":"Platelets guide the formation of early metastatic niches","volume":"111","author":"Labelle","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B55","doi-asserted-by":"publisher","first-page":"645","DOI":"10.5009\/gnl210311","article-title":"CD40 agonists alter the pancreatic cancer microenvironment by shifting the macrophage phenotype toward M1 and suppress human pancreatic cancer in organotypic slice cultures","volume":"16","author":"Lim","year":"2022","journal-title":"Gut Liver"},{"key":"B56","doi-asserted-by":"publisher","first-page":"795159","DOI":"10.3389\/fonc.2022.795159","article-title":"Macrophages and metabolic reprograming in the tumor microenvironment","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Oncol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41590-018-0292-y","article-title":"Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47-mediated 'don't-eat-me' signal","volume":"20","author":"Liu","year":"2019","journal-title":"Nat. Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"720","DOI":"10.2174\/1389450115666140519162133","article-title":"The role of P2Y\u2081\u2082 receptor and activated platelets during inflammation","volume":"15","author":"Liverani","year":"2014","journal-title":"Curr. Drug Targets"},{"key":"B59","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.molimm.2017.12.003","article-title":"Macrophages: key orchestrators of a tumor microenvironment defined by therapeutic resistance","volume":"110","author":"Long","year":"2019","journal-title":"Mol. Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1158\/2159-8290.CD-15-1032","article-title":"IFN\u03b3 and CCL2 cooperate to redirect tumor-infiltrating monocytes to degrade fibrosis and enhance chemotherapy efficacy in pancreatic carcinoma","volume":"6","author":"Long","year":"2016","journal-title":"Cancer Discov."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.3389\/fonc.2020.01350","article-title":"Platelets and metastasis: new implications of an old interplay","volume":"10","author":"Lucotti","year":"2020","journal-title":"Front. Oncol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"e27615","DOI":"10.4161\/onci.27615","article-title":"Understanding the influence of the tumor microenvironment on macrophage responses to CD40 agonists","volume":"3","author":"Luheshi","year":"","journal-title":"Oncoimmunology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/eji.201343351","article-title":"Th1 cytokines are more effective than Th2 cytokines at licensing anti-tumour functions in CD40-activated human macrophages in vitro","volume":"44","author":"Luheshi","year":"","journal-title":"Eur. J. Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.3390\/cells8121584","article-title":"Targeting mTOR and metabolism in cancer: lessons and innovations","volume":"8","author":"Magaway","year":"2019","journal-title":"Cells"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.3390\/cancers13112546","article-title":"CSF1\/CSF1R Axis blockade limits mesothelioma and enhances efficiency of anti-PDL1 immunotherapy","volume":"13","author":"Magkouta","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B66","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/febs.14295","article-title":"Metabolism and TAM functions-it takes two to tango","volume":"285","author":"Mazzone","year":"2018","journal-title":"FEBS J."},{"key":"B67","doi-asserted-by":"publisher","first-page":"688643","DOI":"10.3389\/fimmu.2021.688643","article-title":"The role of CLEC-2 and its ligands in thromboinflammation","volume":"12","author":"Meng","year":"2021","journal-title":"Front. Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1615\/critrevimmunol.v32.i6.10","article-title":"M1 and M2 macrophages: oracles of Health and disease","volume":"32","author":"Mills","year":"2012","journal-title":"Crit. Rev. Immunol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"188770","DOI":"10.1016\/j.bbcan.2022.188770","article-title":"Platelet cancer cell interplay as a new therapeutic target","volume":"1877","author":"Morris","year":"2022","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"B70","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.2147\/IJGM.S320492","article-title":"Cancer-associated thrombosis: A clinical scoping review of the risk assessment models across solid tumours and haematological malignancies","volume":"14","author":"Mosaad","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fcell.2019.00086","article-title":"The role of the extracellular matrix in cancer stemness","volume":"7","author":"Nallanthighal","year":"2019","journal-title":"Front. Cell. Dev. Biol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1160\/TH13-01-0060","article-title":"The physiological and pathophysiological roles of platelet CLEC-2","volume":"109","author":"Navarro-Nunez","year":"2013","journal-title":"Thromb. Haemost."},{"key":"B73","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1093\/carcin\/bgac043","article-title":"CSF-1R inhibitor, pexidartinib, sensitizes esophageal adenocarcinoma to PD-1 immune checkpoint blockade in a rat model","volume":"43","author":"Omstead","year":"2022","journal-title":"Carcinogenesis"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3389\/fimmu.2019.01084","article-title":"Macrophage polarization: different gene signatures in M1(LPS+) vs. Classically and M2(LPS-) vs. Alternatively activated macrophages","volume":"10","author":"Orecchioni","year":"2019","journal-title":"Front. Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.3389\/fimmu.2019.01805","article-title":"Platelets, thrombo-inflammation, and cancer: collaborating with the enemy","volume":"10","author":"Palacios-Acedo","year":"2019","journal-title":"Front. Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"704945","DOI":"10.3389\/fonc.2021.704945","article-title":"P2RY12-Inhibitors reduce cancer-associated thrombosis and tumor growth in pancreatic cancers","volume":"11","author":"Palacios-Acedo","year":"2021","journal-title":"Front. Oncol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/j.celrep.2017.07.054","article-title":"Pharmacologic or genetic targeting of glutamine synthetase skews macrophages toward an M1-like phenotype and inhibits tumor metastasis","volume":"20","author":"Palmieri","year":"2017","journal-title":"Cell. Rep."},{"key":"B78","doi-asserted-by":"publisher","first-page":"119612","DOI":"10.1016\/j.lfs.2021.119612","article-title":"Activated platelets contribute to the progression of hepatocellular carcinoma by altering the tumor environment","volume":"277","author":"Pavlovi\u0107","year":"2021","journal-title":"Life Sci."},{"key":"B79","doi-asserted-by":"publisher","first-page":"8177","DOI":"10.3390\/ijms21218177","article-title":"Inhibiting P2Y12 in macrophages induces endoplasmic reticulum stress and promotes an anti-tumoral phenotype","volume":"21","author":"Pavlovic","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.4049\/jimmunol.160.3.1166","article-title":"IL-12 up-regulates CD40 ligand (CD154) expression on human T cells","volume":"160","author":"Peng","year":"1998","journal-title":"J. Immunol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"e1191731","DOI":"10.1080\/2162402X.2016.1191731","article-title":"Warburg metabolism in tumor-conditioned macrophages promotes metastasis in human pancreatic ductal adenocarcinoma","volume":"5","author":"Penny","year":"2016","journal-title":"Oncoimmunology"},{"key":"B82","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/nrc3603","article-title":"The roles of TGF\u03b2 in the tumour microenvironment","volume":"13","author":"Pickup","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/j.celrep.2016.10.031","article-title":"PF4 promotes platelet production and lung cancer growth","volume":"17","author":"Pucci","year":"2016","journal-title":"Cell. Rep."},{"key":"B84","doi-asserted-by":"publisher","first-page":"108962","DOI":"10.1016\/j.intimp.2022.108962","article-title":"Platelet-rich plasma-derived exosomes attenuate intervertebral disc degeneration by promoting NLRP3 autophagic degradation in macrophages","volume":"110","author":"Qian","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev.immunol.22.012703.104533","article-title":"CD40\/CD154 interactions at the interface of tolerance and immunity","volume":"22","author":"Quezada","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"27460","DOI":"10.18632\/oncotarget.25446","article-title":"PD-L1 is expressed on human platelets and is affected by immune checkpoint therapy","volume":"9","author":"Rolfes","year":"2018","journal-title":"Oncotarget"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1182\/blood.v95.4.1158.004k31_1158_1166","article-title":"The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages","volume":"95","author":"Scheuerer","year":"2000","journal-title":"Blood"},{"key":"B89","doi-asserted-by":"publisher","first-page":"5399","DOI":"10.1182\/blood-2006-12-062943","article-title":"Direct inhibition of CD40L expression can contribute to the clinical efficacy of daclizumab independently of its effects on cell division and Th1\/Th2 cytokine production","volume":"109","author":"Snyder","year":"2007","journal-title":"Blood"},{"key":"B90","doi-asserted-by":"publisher","first-page":"e006263","DOI":"10.1136\/jitc-2022-006263","article-title":"Treg-selective IL-2 starvation synergizes with CD40 activation to sustain durable responses in lymphoma models","volume":"11","author":"Stirm","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"B91","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3390\/cells9040855","article-title":"Platelet-leukocyte interplay in cancer development and progression","volume":"9","author":"Stoiber","year":"2020","journal-title":"Cells"},{"key":"B92","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13058-021-01417-8","article-title":"Attenuated TGFB signalling in macrophages decreases susceptibility to DMBA-induced mammary cancer in mice","volume":"23","author":"Sun","year":"2021","journal-title":"Breast Cancer Res."},{"key":"B93","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1080\/09537104.2018.1478401","article-title":"Roles of the CLEC-2-podoplanin interaction in tumor progression","volume":"29","author":"Suzuki-Inoue","year":"2018","journal-title":"Platelets"},{"key":"B94","doi-asserted-by":"publisher","first-page":"e211","DOI":"10.1038\/cddis.2011.94","article-title":"Microparticles from apoptotic platelets promote resident macrophage differentiation","volume":"2","author":"Vasina","year":"2011","journal-title":"Cell. Death Dis."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3389\/fimmu.2019.01462","article-title":"The metabolic signature of macrophage responses","volume":"10","author":"Viola","year":"2019","journal-title":"Front. Immunol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"939089","DOI":"10.3389\/fonc.2022.939089","article-title":"Emerging roles of platelets in cancer biology and their potential as therapeutic targets","volume":"12","author":"Wang","year":"","journal-title":"Front. Oncol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1097\/CM9.0000000000002426","article-title":"Metabolic reprogramming in the immunosuppression of tumor-associated macrophages","volume":"135","author":"Wang","year":"","journal-title":"Chin. Med. J. Engl."},{"key":"B98","doi-asserted-by":"publisher","first-page":"886132","DOI":"10.3389\/fcvm.2022.886132","article-title":"Platelet-derived exosomes and atherothrombosis","volume":"9","author":"Wei","year":"2022","journal-title":"Front. Cardiovasc Med."},{"key":"B99","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/MNH.0000000000000595","article-title":"The varying roles of macrophages in kidney injury and repair","volume":"29","author":"Wen","year":"2020","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"B100","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.molcel.2019.10.023","article-title":"Cancer-derived succinate promotes macrophage polarization and cancer metastasis via succinate receptor","volume":"77","author":"Wu","year":"2020","journal-title":"Mol. Cell."},{"key":"B101","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.canlet.2016.01.043","article-title":"Tumor microenvironment and therapeutic response","volume":"387","author":"Wu","year":"2017","journal-title":"Cancer Lett."},{"key":"B102","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.canlet.2016.11.006","article-title":"Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-\u03b21\/Gfi-1 axis","volume":"385","author":"Xian","year":"2017","journal-title":"Cancer Lett."},{"key":"B103","doi-asserted-by":"publisher","first-page":"625181","DOI":"10.3389\/fimmu.2021.625181","article-title":"The dual role of platelets in the cardiovascular risk of chronic inflammation","volume":"12","author":"Zamora","year":"2021","journal-title":"Front. Immunol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"19296","DOI":"10.1038\/s41598-020-76351-4","article-title":"Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors","volume":"10","author":"Zaslavsky","year":"2020","journal-title":"Sci. Rep."},{"key":"B105","doi-asserted-by":"publisher","first-page":"620510","DOI":"10.3389\/fimmu.2021.620510","article-title":"Function of macrophages in disease: current understanding on molecular mechanisms","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"52294","DOI":"10.18632\/oncotarget.10561","article-title":"TGF-\u03b2 induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"B107","doi-asserted-by":"publisher","first-page":"5716","DOI":"10.1021\/acs.nanolett.8b02321","article-title":"Engineering PD-1-presenting platelets for cancer immunotherapy","volume":"18","author":"Zhang","year":"2018","journal-title":"Nano Lett."},{"key":"B108","doi-asserted-by":"publisher","first-page":"28806","DOI":"10.18632\/oncotarget.8933","article-title":"Identification of the microRNA networks contributing to macrophage differentiation and function","volume":"7","author":"Zhou","year":"2016","journal-title":"Oncotarget"},{"key":"B109","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.2147\/IJN.S294916","article-title":"Rosuvastatin nanomicelles target neuroinflammation and improve neurological deficit in a mouse model of intracerebral hemorrhage","volume":"16","author":"Zi","year":"2021","journal-title":"Int. J. Nanomedicine"}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2023.1250982\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T14:45:12Z","timestamp":1692888312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2023.1250982\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":109,"alternative-id":["10.3389\/fphys.2023.1250982"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2023.1250982","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,24]]},"article-number":"1250982"}}